Heliospectra AB hires DR. Sue Sisley as director of medicinal plant research

GÖTEBORG, Sweden/SAN FRANCISCO, Calif., Feb. 23, 2015—Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse cultivation and plant research, today announced that it has hired Dr. Sue Sisley as Director of Medicinal Plant Research.

As Director of Medicinal Plant Research at Heliospectra, Dr. Sisley provides the company with “in the field” knowledge and customer feedback. Working with growers to develop scalable medicinal plant growing methodologies, Dr. Sisley oversees data collection and reporting protocol with Heliospectra’s medicinal plant cultivators in the US, Canada and globally.

Dr. Sisley’s research focuses on the use of medicinal cannabis as an effective treatment option for veterans suffering from chronic post-traumatic stress disorder. Directly in line with Heliospectra’s value to growers, Dr. Sisley is capable of helping Heliospectra’s customers understand what chemical profiles a medicinal plant therapy should express.

“The light source offers the opportunity to build specific, consistent medicinal plant therapies. I am proud to be associated with such...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.